MESOMARK verify that it is now possible - with a simple blood test to monitor response to treatment and to detect recurrence after treatment. This provides important information about the patient's head was racing against this aggressive cancer. "Mesoamerica Foundation is a national research funding, patient support and advocacy organization dedicated to eradicating mesothelioma is a deadly disease.
Who needs to attend MESOMARK will be asked to provide three or more blood samples. Blood samples will then be sent to the national reference laboratory for testing. As well as clinical and laboratory information that your doctor can decisions about your care and treatment easier. You can stop the test at a tim
Food and Drug Administration (FDA) has approved the establishment MESOMARK to help monitor response to treatment is patients with malignant mesothelioma. MESOMARK check the beginning of a new era for the monitoring of mesothelioma cancer, said Dr. W. Jeffrey Allard, vice president and chief scientific officer of Fujirebio Diagnostics. "As the first in vitro test for patients with this aggressive disease, allowing doctors to detect recurrence in more detail and to monitor patient care."
Kit to verify the contents of MESOMARK been developed to measure levels of markers, mesothelin, in serum. Biomarkers are substances in concentrations higher than normal in the blood, urine or tissues of patients with cancer. This verification can be used to monitor patients tested mesothelioma, for recurrence in patients after surgery, or for measuring response to treatment.
"This diagnostic test is far from ideal for the quantification of changes in tumor volume, which is essential to managing the disease," continued Allard. "As the results correlated with MESOMARK * tumor volume, it provides an indispensable tool to monitor the patient's condition. Thus they intend to collect additional information in the future to support the use of a check to detect mesothelioma. "
Who needs to attend MESOMARK will be asked to provide three or more blood samples. Blood samples will then be sent to the national reference laboratory for testing. As well as clinical and laboratory information that your doctor can decisions about your care and treatment easier. You can stop the test at a tim
Food and Drug Administration (FDA) has approved the establishment MESOMARK to help monitor response to treatment is patients with malignant mesothelioma. MESOMARK check the beginning of a new era for the monitoring of mesothelioma cancer, said Dr. W. Jeffrey Allard, vice president and chief scientific officer of Fujirebio Diagnostics. "As the first in vitro test for patients with this aggressive disease, allowing doctors to detect recurrence in more detail and to monitor patient care."
Kit to verify the contents of MESOMARK been developed to measure levels of markers, mesothelin, in serum. Biomarkers are substances in concentrations higher than normal in the blood, urine or tissues of patients with cancer. This verification can be used to monitor patients tested mesothelioma, for recurrence in patients after surgery, or for measuring response to treatment.
"This diagnostic test is far from ideal for the quantification of changes in tumor volume, which is essential to managing the disease," continued Allard. "As the results correlated with MESOMARK * tumor volume, it provides an indispensable tool to monitor the patient's condition. Thus they intend to collect additional information in the future to support the use of a check to detect mesothelioma. "
No comments:
Post a Comment